Undergraduate education

University of Wisconsin-Madison, BS, 2002

Years in MSTP



Cancer biology, 2008


Christopher Bradfield, PhD

Thesis title

The aryl hydrocarbon receptor in mammalian development


Internal medicine, University of Washington, 2010-2013


Hematology and oncology, University of Washington, 2013-2017

Current position

Acting instructor, Department of Medical Oncology, University of Washington, School of Medicine

PhD publications

Stevens EA, Mezrich JD, Bradfield CA. The aryl hydrocarbon receptor: a perspective on potential roles in the immune system. Immunology. 2009 Jul;127(3):299-311. PMID: 19538249; PMCID: PMC2712099.

Stevens EA, Bradfield CA. Immunology: T cells hang in the balance. Nature. 2008 May 1;453(7191):46-7. PMID: 18451850.

Dunham EE, Stevens EA, Glover E, Bradfield CA. The aryl hydrocarbon receptor signaling pathway is modified through interactions with a Kelch protein. Mol Pharmacol. 2006 Jul;70(1):8-15. PubMed PMID: 16582008.

Thomae TL, Stevens EA, Liss AL, Drinkwater NR, Bradfield CA. The teratogenic sensitivity to 2,3,7,8-tetrachlorodibenzo-p-dioxin is modified by a locus on mouse chromosome 3. Mol Pharmacol. 2006 Mar;69(3):770-5. PMID: 16354765.

Thomae TL, Stevens EA, Bradfield CA. Transforming growth factor-beta3 restores fusion in palatal shelves exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Biol Chem. 2005 Apr 1;280(13):12742-6. PMID: 15668235.